Satoko Kishimoto Selected Research

Powders

1/2010

Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoko Kishimoto Research Topics

Disease

12	Wounds and Injuries (Trauma) 01/2020 - 07/2007
6	Ischemia 01/2020 - 09/2011
3	Neoplasms (Cancer) 07/2019 - 08/2017
2	Stress Urinary Incontinence 10/2022 - 06/2018
2	Hypoxia (Hypoxemia) 07/2019 - 08/2012
2	Peripheral Arterial Disease 01/2013 - 09/2011
2	Chronic Limb-Threatening Ischemia 01/2013 - 09/2011
2	Hemorrhage 04/2012 - 04/2010
1	Atrial Fibrillation 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Atherosclerosis 01/2023
1	Vascular System Injuries 01/2023
1	Squamous Cell Carcinoma of Head and Neck 12/2022
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Carcinoma (Carcinomatosis) 10/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2013
1	Synostosis 09/2013
1	Shock 08/2012
1	Skin Ulcer 01/2012
1	Infections 10/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2008

Drug/Important Bio-Agent (IBA)

5	ChitosanIBA 09/2013 - 01/2010
4	HydrogelsIBA 09/2013 - 01/2010
3	Protamines (Protamine Sulfate)FDA Link 01/2016 - 09/2011
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 10/2008
3	fucoidanIBA 01/2012 - 01/2010
3	AlginatesIBA 01/2012 - 01/2010
3	ChitinIBA 01/2012 - 01/2010
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2010 - 07/2007
2	Dalteparin (Dalteparin Sodium)FDA Link 01/2013 - 09/2011
2	SolutionsIBA 12/2012 - 01/2010
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2012 - 09/2011
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2011 - 10/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011 - 03/2009
2	atelocollagenIBA 01/2011 - 07/2007
1	Factor Xa InhibitorsIBA 01/2023
1	erucylphosphocholineIBA 01/2023
1	RivaroxabanIBA 01/2023
1	AnticoagulantsIBA 01/2023
1	Warfarin (Coumadin)FDA LinkGeneric 01/2023
1	antineoplaston A10 (A 10)IBA 12/2022
1	AnnexinsIBA 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 07/2019
1	Cisplatin (Platino)FDA LinkGeneric 07/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019
1	Tissue Adhesives (Tissue Adhesive)IBA 04/2019
1	Peptide Hydrolases (Proteases)FDA Link 10/2018
1	Matrix Metalloproteinases (MMPs)IBA 10/2018
1	Thymidine KinaseIBA 08/2017
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2013
1	SuspensionsIBA 11/2012
1	Fatty Acid-Binding ProteinsIBA 08/2012
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2012
1	Epinephrine (Adrenaline)FDA LinkGeneric 08/2012
1	CatecholaminesIBA 08/2012
1	liposome-encapsulated hemoglobinIBA 08/2012
1	Hypertonic Saline SolutionIBA 04/2012
1	Colloids (Colloid)IBA 01/2012
1	tachocombIBA 04/2010
1	PowdersIBA 01/2010
1	CytokinesIBA 03/2009
1	Heparin (Liquaemin)FDA LinkGeneric 10/2008
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2008
1	Polystyrenes (Polystyrene)IBA 10/2008
1	Collagen Type I (Type I Collagen)IBA 10/2008
1	SiliconesIBA 07/2007

Therapy/Procedure

3	Transplantation 06/2018 - 07/2007
2	Therapeutics 01/2013 - 09/2011
2	Injections 12/2012 - 11/2012
2	Intramuscular Injections 12/2012 - 11/2012
1	Percutaneous Coronary Intervention 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022
1	Operative Surgical Procedures 01/2020
1	Heterotopic Transplantation 06/2018
1	Ligation 01/2016
1	Hemodilution 08/2012
1	Hair Removal (Depilation) 01/2012
1	Aftercare (After-Treatment) 03/2009